213 related articles for article (PubMed ID: 8605607)
1. Molybdenum and copper kinetics after tetrathiomolybdate injection in LEC rats: specific role of serum albumin.
Suzuki KT; Ogra Y; Ohmichi M
J Trace Elem Med Biol; 1995 Oct; 9(3):170-5. PubMed ID: 8605607
[TBL] [Abstract][Full Text] [Related]
2. Systemic dispositions of molybdenum and copper after tetrathiomolybdate injection in LEC rats.
Ogra Y; Ohmichi M; Suzuki KT
J Trace Elem Med Biol; 1995 Oct; 9(3):165-9. PubMed ID: 8605606
[TBL] [Abstract][Full Text] [Related]
3. Effect of glutathione depletion on removal of copper from LEC rat livers by tetrathiomolybdate.
Ogra Y; Miyayama T; Anan Y
J Inorg Biochem; 2010 Aug; 104(8):858-62. PubMed ID: 20427090
[TBL] [Abstract][Full Text] [Related]
4. Targeting of tetrathiomolybdate on the copper accumulating in the liver of LEC rats.
Ogra Y; Suzuki KT
J Inorg Biochem; 1998 Apr; 70(1):49-55. PubMed ID: 9661287
[TBL] [Abstract][Full Text] [Related]
5. Excretion of copper complexed with thiomolybdate into the bile and blood in LEC rats.
Komatsu Y; Sadakata I; Ogra Y; Suzuki KT
Chem Biol Interact; 2000 Feb; 124(3):217-31. PubMed ID: 10728780
[TBL] [Abstract][Full Text] [Related]
6. Removal and efflux of copper from Cu-metallothionein as Cu/tetrathiomolybdate complex in LEC rats.
Ogra Y; Suzuki KT
Res Commun Mol Pathol Pharmacol; 1995 May; 88(2):196-204. PubMed ID: 7670851
[TBL] [Abstract][Full Text] [Related]
7. Removal of copper from the liver of Long-Evans Cinnamon (LEC) rats by tetrathiomolybdate (TTM) injection: the main excretion route is via blood, not bile.
Sugawara N; Li D; Sugawara C
Res Commun Mol Pathol Pharmacol; 1994 Aug; 85(2):217-26. PubMed ID: 7994566
[TBL] [Abstract][Full Text] [Related]
8. Formation of copper-metallothionein/tetrathiomolybdate complex is the first step in removal of Cu from LEC rats.
Suzuki KT; Ogra Y
Res Commun Mol Pathol Pharmacol; 1995 May; 88(2):187-95. PubMed ID: 7670850
[TBL] [Abstract][Full Text] [Related]
9. Metabolic fate of the insoluble copper/tetrathiomolybdate complex formed in the liver of LEC rats with excess tetrathiomolybdate.
Ogra Y; Chikusa H; Suzuki KT
J Inorg Biochem; 2000 Jan; 78(2):123-8. PubMed ID: 10766335
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of tetrathiomolybdate on hepatic dysfunction occurring naturally in Long-Evans Cinnamon (LEC) rats: a bona fide animal model for Wilson's disease.
Sugawara N; Lai YR; Sugawara C
Res Commun Mol Pathol Pharmacol; 1999 Feb; 103(2):177-87. PubMed ID: 10461684
[TBL] [Abstract][Full Text] [Related]
11. Tetrathiomolybdate in the treatment of acute hepatitis in an animal model for Wilson disease.
Klein D; Arora U; Lichtmannegger J; Finckh M; Heinzmann U; Summer KH
J Hepatol; 2004 Mar; 40(3):409-16. PubMed ID: 15123354
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of selective copper removal by tetrathiomolybdate from metallothionein in LEC rats.
Ogra Y; Ohmichi M; Suzuki KT
Toxicology; 1996 Jan; 106(1-3):75-83. PubMed ID: 8571404
[TBL] [Abstract][Full Text] [Related]
13. Disordered copper metabolism in LEC rats, an animal model of Wilson disease: roles of metallothionein.
Suzuki KT
Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):221-40. PubMed ID: 8556276
[TBL] [Abstract][Full Text] [Related]
14. Copper balance and ceruloplasmin in chronic hepatitis in a Wilson disease animal model, LEC rats.
Komatsu Y; Ogra Y; Suzuki KT
Arch Toxicol; 2002 Sep; 76(9):502-8. PubMed ID: 12242607
[TBL] [Abstract][Full Text] [Related]
15. Outputs of hepatic copper and cadmium stimulated by tetrathiomolybdate (TTM) injection in Long-Evans Cinnamon (LEC) rats pretreated with cadmium, and in Fischer rats pretreated with copper and cadmium.
Lai YR; Sugawara N
Toxicology; 1997 Jun; 120(1):47-54. PubMed ID: 9160108
[TBL] [Abstract][Full Text] [Related]
16. Tetrathiomolybdate causes formation of hepatic copper-molybdenum clusters in an animal model of Wilson's disease.
George GN; Pickering IJ; Harris HH; Gailer J; Klein D; Lichtmannegger J; Summer KH
J Am Chem Soc; 2003 Feb; 125(7):1704-5. PubMed ID: 12580588
[TBL] [Abstract][Full Text] [Related]
17. Comparative mechanism and toxicity of tetra- and dithiomolybdates in the removal of copper.
Ogra Y; Komada Y; Suzuki KT
J Inorg Biochem; 1999 Jun; 75(3):199-204. PubMed ID: 10474204
[TBL] [Abstract][Full Text] [Related]
18. Copper in plasma reflects its status and subsequent toxicity in the liver of LEC rats.
Rui M; Suzuki KT
Res Commun Mol Pathol Pharmacol; 1997 Dec; 98(3):335-46. PubMed ID: 9485527
[TBL] [Abstract][Full Text] [Related]
19. Metabolic disposition of WTX101 (bis-choline tetrathiomolybdate) in a rat model of Wilson disease.
Plitz T; Boyling L
Xenobiotica; 2019 Mar; 49(3):332-338. PubMed ID: 29460662
[TBL] [Abstract][Full Text] [Related]
20. Tracing copper-thiomolybdate complexes in a prospective treatment for Wilson's disease.
Zhang L; Lichtmannegger J; Summer KH; Webb S; Pickering IJ; George GN
Biochemistry; 2009 Feb; 48(5):891-7. PubMed ID: 19146437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
